
    
      To create a local registry of retrospective and prospective patients on ECMO at Spectrum
      Health, Butterworth campus in order to optimize the use of ECMO therapy and to create
      algorithms to estimate the prognosis. ECMO patients will be compared to a control group of
      patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year
      after the start of ECMO therapy.
    
  